Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cue Biopharma, Inc.

0.7249
+0.00110.15%
Post-market: 0.74420.0193+2.66%19:53 EDT
Volume:120.37K
Turnover:88.12K
Market Cap:54.62M
PE:-1.11
High:0.7514
Open:0.7300
Low:0.7200
Close:0.7238
Loading ...
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 24, 2023

Correspondence

Form CORRESP - Correspondence
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2023

Major Issues Report

8-K - Current report
Apr 12, 2023

Major Issues Report

8-K - Current report
Mar 21, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 21, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 12, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 02, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 18, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 15, 2022

Major Issues Report

8-K - Current report